Autoimmune diseases and pregnancy.
autoimmune diseases
pregnancy
systematic review
Journal
Best practice & research. Clinical endocrinology & metabolism
ISSN: 1878-1594
Titre abrégé: Best Pract Res Clin Endocrinol Metab
Pays: Netherlands
ID NLM: 101120682
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
pubmed:
23
9
2019
medline:
20
5
2020
entrez:
23
9
2019
Statut:
ppublish
Résumé
Pregnancy in autoimmune diseases remains an argument of debate. In last years great improvements were done and with the correct medical support women with disease such as Systemic Lupus Erythematosus or Antiphospholipid Syndrome can afford a pregnancy and have healthy babies. The starting point is a good counselling. Women should be informed about risks that can occur taking some medications while pregnant and, on the other hand, that there are medications that can be safety assumed during pregnancy. Furthermore, there are known maternal risks factor such as the presence of antiphospholipid antibodies or anti-Ro/SSA antibodies that must be carefully manage by both rheumatologists and obstetrics. In addition, also disease activity during pregnancy can represent an issue. For all these reason, a multidisciplinary approach is mandatory in order to give our patients an optimal medical support, before, during and after pregnancy.
Identifiants
pubmed: 31542218
pii: S1521-690X(19)30073-9
doi: 10.1016/j.beem.2019.101322
pii:
doi:
Substances chimiques
Antibodies, Antinuclear
0
SS-A antibodies
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101322Informations de copyright
Copyright © 2019. Published by Elsevier Ltd.